Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> ActivityThomas H. Pillow, Peter S. Dragovich, Richard Zang et al.|ChemMedChem|2019Cited by 193
Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug ConjugatesJeffrey C. Kern, R. M. Garbaccio, Peter Stivers et al.|Journal of the American Chemical Society|2016Cited by 141
Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune CellsPhilip E. Brandish, Mark Zielstorff, Mark T. Cancilla et al.|Bioconjugate Chemistry|2018Cited by 58